%%%ELECTION OF MEMBERS|

2014 session Item 4 of the provisional agenda* * E/2014/1/Rev.1, annex II. Elections, nominations, confirmations and appointments Election of one member of the International Narcotics Control Board from among candidates nominated by the World Health Organization Note by the Secretary-General 1. The present note contains information on candidates nominated by the World Health Organization (WHO). Information on candidates nominated by Governments is contained in documents E/2014/9/Add.7 and Add.8. 2. In accordance with established procedure, the Secretary-General invited the Director-General of WHO to submit a list of candidates for election to membership in the International Narcotics Control Board for the period from 2 March 2015 to 1 March 2020 on the expiration of the term of office of one member of the Board who was originally nominated by WHO and elected by the Economic and Social Council in 2009. The post is currently occupied by Rajat Ray (India). 3. As at 20 January 2014, three candidates had been proposed by WHO. Their names are given below in alphabetical order: Michel Bourin France Jaanus Harro Estonia Rajat Ray (re-election) India 4. The biographical information that was transmitted with the proposals for candidatures is contained in the annex to the present note. 5. In accordance with article 9, paragraph 2, of the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol, members of the Board shall not hold positions or engage in any activity that would be liable to impair their impartiality in the exercise of their functions. Positions and activities of individuals in the following areas are, in particular, incompatible with membership of the Board: persons who hold government posts, are in the paid service of their Governments or are acting under instructions from their Governments; persons who represent a Government at national or international forums on drug-related issues; and persons who are engaged in any activity, whether private or public, that might be liable to impair their impartiality in the exercise of their functions on the Board or whose activity is in conflict with the functions of the Board. 6. Document E/2014/9/Add.7 contains information on the number, length and place of meetings of the Board in 2013, on payments to members and on present membership (annex I); articles 9 (Composition and functions of the Board) and 10 (Terms of office and remuneration of members of the Board) of the Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol (annex II); information on qualifications and other conditions of membership on the Board (annex III); and a list of the States parties to the Single Convention of 1961 and that Convention as amended by the 1972 Protocol, the Convention on Psychotropic Substances of 1971 and the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (annex IV). * Curricula vitae are issued without formal editing. Biographical information on candidates for election to the International Narcotics Control Board* 1. Michel Bourin (France) Education Medical Doctor, University of Tours, 1979; Pharmaceutical Doctor, University of Tours, 1970; degrees in Neuropsychopharmacology, Clinical Pharmacology and General Pharmacology, University of Paris, 1977-1978; Psychiatrist, National Committee of the French Medical Board, 1997. Doctor honoris causa: University of Tartu (Estonia) and University of Craiova (Romania). Present posts Retired. Previous posts Professor of Pharmacology, University of Nantes, 1985-2012; Expert on drug dependency, World Health Organization (WHO), 2000-2012; Adjunct Professor, Department of Psychiatry, University of Edmonton (Alberta, Canada), 1995-2006; Visiting Professor, University of Craiova (Romania); Head of Research: neurobiology of anxiety and depression (University of Nantes), from 1988; scientific expert for the European Accreditation Committee for continuing medical education in central nervous system medicine. Chief Editor, Frontiers in Psychopharmacology; Associate editor, Neuropsychiatry; Field editor, Fundamental and Clinical Pharmacology. Publications More than 300 original papers in the field of psychopharmacology. More than 250 educational/review papers, chapters both in French and English. Memberships Member of the Board of: Current Psychiatry Reviews; Current Psychopharmacology; European Neuropsychopharmacology, 1990-1998; Fundamental and Clinical Pharmacology; International Clinical Psychopharmacology; Journal of Psychiatry and Neurosciences; Human Psychopharmacology: Clinical and Experimental; Klinick Psykofarmacologi Bülteni (Turkey); Neuropsychobiology; Pakistan Journal of Pharmaceutical Sciences; Pharmacology and Pharmacy; Romanian Journal of Psychopharmacology; Saudi Pharmaceutical Journal; World Journal of Psychiatry. Member of the International College of Neuropsychopharmacology, the European College of Neuropsychopharmacology, the Canadian College of Neuropsychopharmacology, the British Association for Psychopharmacology. Treasurer of the European College of Neuropsychopharmacology, 1995-2002. Graduated (M.D.) from the Faculty of Medicine, University of Tartu, Estonia, (1987); postgraduate studies in psychopharmacology at the Department of Pharmacology, University of Tartu (1987-1990); Ph.D. in Pharmacology, University of Tartu (1990). Doctor of Medical Science, Uppsala University, Sweden (1993). Present post Professor of Psychophysiology, Department of Psychology, University of Tartu (since 1998). Full Professor of Health Promotion (personal appointment), Estonian health project affiliated to the Department of Public Health, University of Tartu, Estonia (1996-1998); Vice-Dean, Preclinical Medicine, Faculty of Medicine, University of Tartu (1994-1998); Professor of Neuropsychopharmacology (personal appointment), Department of Pharmacology, University of Tartu (1994-1996); Senior Researcher in Neurobiology, Head, Psychopharmacology Unit, Department of Physiology, University of Tartu (1993); Acting Head of the Laboratory of Psychopharmacology, Institute of General and Molecular Pathology, University of Tartu (1993); Assistant Professor in Basic Pharmacology, University of Tartu (1989-1990); Staff Scientist at the Laboratory of Psychopharmacology, Institute of General and Molecular Pathology, University of Tartu (1989-1992); Research Associate at the Department of Pharmacology, University of Tartu (1987-1989). Collegium Internationale Neuro-Psychopharmacologicum (International College of Neuropsychopharmacology -- CINP), Member of the Education Committee since June 2004; Society for Neuroscience; European College of Neuropsychopharmacology; International Society of Psychoneuroendocrinology; International Brain Research Organization; Estonian Society of Pharmacology; Estonian Union of Psychologists; Estonian Society of Psychiatrists; National Geographic Society; Foreign Member, the Royal Society of Sciences at Uppsala (Class for Natural History and Medicine) (2011). More than 170 papers and chapters in internationally, broadly available journals and books, inter alia: In the Age of Intoxicants, ISBN 9949-11-214-1; 317 pages), Tartu University Press, 2006 (monograph, in Estonian); S. Oreland, K. Raudkivi, L. Oreland, J. Harro, L. Arborelius and I. Nylander, "Ethanol-induced effects on the dopamine and serotonin systems in adult Wistar rats are dependent on early-life experiences" Brain Research (2011) 1405, 57-68; L. Merenäkk, J. Mäestu, N. Nordquist, J. Parik, L. Oreland, H.-M. Loit and J. Harro, "Effects of the serotonin transporter (5-HTTLPR) and α2A-adrenoceptor (C-1291G) genotypes on substance use in children and adolescents: a longitudinal study", Psychopharmacology (2011) 215, 13-22; J. Harro, "Inter-individual differences in neurobiology as vulnerability factors for affective disorders: implications for psychopharmacology". Pharmacology and Therapeutics (2010) 125, 402-422; A. L. Garcia-Garcia, N. Elizalde, D. Matrov, J. Harro, S. M. Wojcik, E. Venzala, M. J. Ramirez, J. Del Rio and R. M. Tordera, "Increased vulnerability to depressive-like behaviour of mice with decreased expression of VGLUT1", Biological Psychiatry (2009) 66, 275-282; A. Alttoa, M. Eller, L. Herm, A. Rinken and J. Harro, "Amphetamine-induced locomotion, behavioural sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus". Brain Research (2007) 1131, 138-148. Honours European College of Neuropsychopharmacology Fellowship Award (1993); CINP Ole Rafaelsen Fellowship Award (1998); Medal of the City of Tartu (2002); National Annual Prize in Medical Sciences (2005); Order of the White Star, Class IV (2006). Meetings attended Invited to speak at more than 30 international conferences, inter alia: EuroScience Open Forum, Dublin, 11-15 July 2012; Haifa Forum for Brain and Behaviour, Haifa, 5-7 February 2012; Conference of the International Society for the Study of Individual Differences, London, 25-28 July 2011; conferences and congresses of the European College of Neuropsychopharmacology. MBBS in Medicine, Medical College, Calcutta, India (1971); MD in Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India (1977). Professor and Head of Department of Psychiatry and Chief of the National Drug Dependence Treatment Centre (NDDTC), AIIMS, New Delhi, India; Member of the International Narcotics Control Board (INCB) (since 2010). Second Vice-President, INCB (2011); Member of the Standing Committee on Estimates, INCB (2012 and 2013); Professor and Head, Department of Psychiatry and Chief, NDDTC, AIIMS (2002); Professor, Department of Psychiatry, AIIMS (2000); Additional Professor, NDDTC, AIIMS, New Delhi (1988-2000); Additional Professor, Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore (1986-1988); Associate Professor, Department of Psychiatry, NIMHANS, Bangalore (1986); Assistant Professor, Department of Psychiatry, NIMHANS, Bangalore (1980-1986). Other relevant professional experience: Consultant to the team to develop resources for training in drug dependence, injection drug use and HIV risk reduction (University of California, Los Angeles (UCLA), United States of America and AIIMS project) (2005-present); consultant to the team to develop technical guidelines and resources for training in drug dependence (UCLA and United Nations Office on Drugs and Crime (UNODC), Vienna) (2005-2006); Research and Policy Adviser for project "Networking for Reducing Risk-Taking Behaviour among Young Drug Users in South Asia" (UNODC) (2004-2005); Research and Policy Adviser for a project on mainstreaming HIV/AIDS concerns in efforts to reduce drug demand in South Asia (a project of the Government of India and UNODC) (2003-2004); technical resource person to modify the National Drug Abuse Control Programme of the Government (Ministry of Health and Family Welfare) (2003). Member, Technical Resource Group on Intravenous Drug Users and AIDS, National AIDS Control Organisation (NACO), Ministry of Health and Family Welfare, Government of India (2000). Author of several technical reports and articles in peer-reviewed national and international journals. Assistant Editor, Addiction Biology. Member of the International Advisory Board of Mental Health and Substance Use: Dual Diagnosis and Member of the Editorial Board of the scientific journal International Drug Sciences and Drug Policy. Selected publications in recent years include: "National drug abuse situation in Vietnam -- How accurate are the projections?" (Commentary), Addiction (2008); S. De, R. Jain, R. Ray, A. Dhawan and S. T. Varghese, "Assessment of differential doses of buprenorphine for long-term pharmacotherapy among opiate dependent subjects", Indian Journal of Physiology and Pharmacology (January-March 2008). 